Gastroenterology News and Research

RSS
UTHealth researchers study how probiotic may help reduce gut inflammation in infants with colic

UTHealth researchers study how probiotic may help reduce gut inflammation in infants with colic

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Study shows IBD patients may have increased risk of heart attack, stroke

Study shows IBD patients may have increased risk of heart attack, stroke

Mayo Clinic: Physical activity is associated with reduced risk of esophageal cancer

Mayo Clinic: Physical activity is associated with reduced risk of esophageal cancer

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

New study illustrates impact of oral nutrition supplement use in pediatric hospitalized patients

New study illustrates impact of oral nutrition supplement use in pediatric hospitalized patients

WHO: Iron deficiency causes loss of 48,225 disability-adjusted life-years worldwide

WHO: Iron deficiency causes loss of 48,225 disability-adjusted life-years worldwide

Crospon's EsoFLIP balloon dilation catheter gets FDA clearance

Crospon's EsoFLIP balloon dilation catheter gets FDA clearance

AGA partners with PENTAX Medical to improve patient care via innovative medical technologies

AGA partners with PENTAX Medical to improve patient care via innovative medical technologies

NUS, A*STAR establish joint center to study role of nutrition and development in health, disease in Asia

NUS, A*STAR establish joint center to study role of nutrition and development in health, disease in Asia

Researchers find ways to identify, isolate HCC progenitor cells before tumors become evident

Researchers find ways to identify, isolate HCC progenitor cells before tumors become evident

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

Adding danoprevir to treatment regimen for hepatitis C patients leads to high rates of remission

EGS announced that enrollment for RESPECT study has surpassed company's original target

EGS announced that enrollment for RESPECT study has surpassed company's original target

Francisco Partners invests in NexTech

Francisco Partners invests in NexTech

Blocking pathway might prevent esophageal cancer in patients with existing Barrett's esophagus

Blocking pathway might prevent esophageal cancer in patients with existing Barrett's esophagus

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

Radiofrequency ablation leads to remission of dysplastic Barrett's esophagus

Radiofrequency ablation leads to remission of dysplastic Barrett's esophagus

Researchers develop renal risk index to predict post-transplant end-stage renal disease

Researchers develop renal risk index to predict post-transplant end-stage renal disease

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

PENTAX Medical launches MagniView optical zoom technology for gastroenterology practice

PENTAX Medical launches MagniView optical zoom technology for gastroenterology practice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.